The study evaluated asundexian (50 mg), a once-daily oral anticoagulant candidate, versus placebo—both given alongside standard antiplatelet therapy
The aim is to bolster healthcare delivery in a region increasingly burdened by chronic disease
he innovation could pave the way for early and low-cost screening of smoking exposure and second-hand smoke biomarkers
Outlines nine priority health tracks spanning TB research, digital health, early warning systems and regulatory cooperation
The CE Mark builds on the company’s ISO 13485 certification, further strengthening confidence in the platform's safety, quality and performance
The 12-month alpha-testing phase will bring together ZEISS R&D, three academic collaborators, and three pharmaceutical industry partners
CDSCO-cleared BSM-5700 series targets ICU, NICU, ER, OR and digital health integration under ABDM
Move amid evidence of widespread reporting gaps
_256_384.jpg)
Effective recovery at home begins with well-defined care plans that outline treatment protocols, recovery milestones, and monitoring requirements tailored to individual patient needs
A brand from Opella will be part of the official NASA astronaut formulary
Subscribe To Our Newsletter & Stay Updated
